Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01294449 · ClinicalTrials.gov registry record
Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Post Approval Registry
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 394
- Enrollment target
NCT01294449 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 394 participants.
The verdict
NCT01294449 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 394 participants
- Enrollment target
Study Summary
MADIT-CRT PAR is an FDA mandated follow-up registry for patients that participated in the MADIT-CRT IDE study examining long-term mortality. (MADIT-CRT IDE: NCT00180271)
Interventions
- DEVICE MADIT-CRT ICD
- DEVICE MADIT-CRT CRT-D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 394 participants |
| Start Date | 2011-03 |
| Est. Completion | 2013-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01294449
The ClinicalTrials.gov registry entry for NCT01294449 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 394 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MADIT-CRT ICD is the first listed.
NCT01294449 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01294449 about?
NCT01294449 is a clinical study titled "Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Post Approval Registry". MADIT-CRT PAR is an FDA mandated follow-up registry for patients that participated in the MADIT-CRT IDE study examining long-term mortality. (MADIT-CRT IDE: NCT00180271)
What is the current status of trial NCT01294449?
This trial is currently completed. The enrollment target is 394 participants. The study started on 2011-03. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01294449?
The interventions under investigation include: MADIT-CRT ICD (DEVICE), MADIT-CRT CRT-D (DEVICE).
Who is sponsoring clinical trial NCT01294449?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.